Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Cerner (CERN) Teams Up With Nebraska-Based LRHC, Shares Up

Published 01/15/2019, 08:46 PM
Updated 07/09/2023, 06:31 AM

Maintaining its streak of collaborations, Cerner Corporation (NASDAQ:CERN) recently teamed up for a 10-year agreement with Nebraska-based Lexington Regional Health Center (“LRHC”). Notably, through the alliance, Cerner’s coveted Millennium platform will be transforming LRHC’s electronic health record ("EHR").

Moreover, the Virginia Department of Behavioral Health and Developmental Services recently picked Cerner Millennium to implement a new EHR at its 13 facilities across Virginia.

Following the announcements, Cerner’s shares rose 0.8% to $54.45 at close.

Cerner Millennium in Focus

Cerner Millennium is a health care IT ("HCIT") platform which maintains a digital record that brings together each patient’s health information from different care venues. This provides doctors and nurses with an up-to-date view of a patient’s well-being.

Notably, the Millennium platform will be deployed in LRHC through Cerner CommunityWorks, a cloud-based model, tailored to meet the unique needs of community, critical access and specialty hospitals.

It is encouraging to note that Cerner Millennium has witnessed solid demand in recent times.

Last December, Cerner Millennium platform was selected by Mid-Valley Hospital to establish a one patient-centric EHR. (Read More: Cerner's Millennium Picked by Mid-Valley Hospital)

Last October, Cerner Millennium was integrated with B. Braun Medical’s Infusomat Space Large Volume Pumps at the McLaren Greater Lansing Hospital, Michigan. (Read More: Cerner's Millennium Platform Integrated at McLaren Hospital)

HCIT Market Prospects

MarketsandMarkets predicts that the global HCIT market will reach a worth of $280.25 billion by 2021 at a CAGR of 15.9%.

Factors such as growing need to manage regulatory compliance through HCIT solutions, government support and rising need to curtail healthcare costs drive the market.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Hence, the slew of developments has been well-timed for Cerner.

Price Performance

Over the past six months, the stock slipped 10.7% comparing favorably with the industry’s 14% decline. The current level is however lower than the S&P 500 index’s 8.3% decline.

For investor’s notice, the Missouri-based provider of HCIT solutions faces stiff competition from players like athenahealth (NASDAQ:ATHN) and Allscripts Healthcare Solutions (NASDAQ:MDRX) .

Zacks Rank & A Key Pick

Cerner currently carries a Zacks Rank #3 (Hold).

A better-ranked stock in the broader medical space is Becton, Dickinson and Company (NYSE:BDX) .

Becton, Dickinson’s long-term earnings growth rate is projected at 11.5%. The stock carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>



Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.